The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

BACKGROUND: Immune-inflammatory biomarkers (IIBs) showed a prognostic relevance in patients with metastatic CRC (mCRC). We aimed at evaluating the prognostic power of a new comprehensive biomarker, the Pan-Immune-Inflammation Value (PIV), in patients with mCRC receiving first-line therapy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Fucà, Giovanni, Guarini, Vincenzo, Antoniotti, Carlotta, Morano, Federica, Moretto, Roberto, Corallo, Salvatore, Marmorino, Federica, Lonardi, Sara, Rimassa, Lorenza, Sartore-Bianchi, Andrea, Borelli, Beatrice, Tampellini, Marco, Bustreo, Sara, Claravezza, Matteo, Boccaccino, Alessandra, Murialdo, Roberto, Zaniboni, Alberto, Tomasello, Gianluca, Loupakis, Fotios, Adamo, Vincenzo, Tonini, Giuseppe, Cortesi, Enrico, de Braud, Filippo, Cremolini, Chiara, Pietrantonio, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403416/
https://www.ncbi.nlm.nih.gov/pubmed/32424148
http://dx.doi.org/10.1038/s41416-020-0894-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403416/
https://www.ncbi.nlm.nih.gov/pubmed/32424148
http://dx.doi.org/10.1038/s41416-020-0894-7

Ejemplares similares